Accelerant Earns Buy Rating on Strong Premium Growth, Raised Outlook, and Compelling Valuation Discount

William Blair analyst Adam Klauber has maintained their bullish stance on ARX stock, giving a Buy rating today.

Adam Klauber has given his Buy rating due to a combination of factors, including Accelerant’s stronger‑than‑expected 16% exchange written premium growth, solid net revenue retention, and stable loss ratio performance that collectively point to a durable underwriting and distribution engine. He also highlights that the business is largely focused on low‑limit specialty risks with steady pricing and limited pressure from admitted carriers, supporting above‑market premium expansion and reinforcing confidence in the sustainability of current trends.

In addition, Klauber emphasizes management’s raised full‑year outlook for both premium growth and adjusted EBITDA, alongside guidance that implies accelerating growth into the second half of the year, which could drive upside versus current expectations. He notes that as the mix shifts further toward less complex, non‑underwriting activities, the investment story should become easier for investors to understand, and with ARX trading at a discount multiple relative to brokers despite meaningfully higher expected earnings growth, the valuation appears compelling for long‑term shareholders.

In another report released today, Piper Sandler also maintained a Buy rating on the stock with a $13.00 price target.